Helicobacter pylori eradication at the patients with duodenal ulcer by the azithromycin and amoxycillin short-term treatment

Antibiotiki i Khimioterapiya

Volumn 47, Issue 2, 2002, Pages 16-19

  Reshetnyak, V I ^a   Dudik, T V ^a   Solovieva, N A ^a   Zhukhovitsky, V G ^a   Ilchenko, A A ^a   Kaprelyants, A S ^a  

^a BACH INSTITUTE OF BIOCHEMISTRY   (Russian Federation)

Author keywords

Amoxycillin; Azithromycin; Duodenal ulcer; Eradication; Helicobacter pylori; Omeprazole; Short term treatment

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; TIME;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DUODENAL ULCER; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0036053523     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report 2. Gut, 2000; 41: 8-13
2. Ling T., Cheng A., Sung J. et al. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter 1996; 1: 57-61.
3. Trautmann M., Riediger C., Moricke A. et al. Combined activity of azithromycin and lansoprazole against Helicobacter pylori. Helicobacter 1999; 4: 113-120.
4. Principi N., Esposito S. Comparative tolerability of enthromycin and newer macrolide antibactenals in pediatric patients. Drug Saf. 1999; 20: 25
5. Glupchinski Y. Culture of Helicobacter pylori from gastric biopsies and antimicrobial susceptibility testing./Lee A., Mégraud F. eds. Helicobacter pylori: techniques for clinical diagnosis and basic research. New York 1996, 17-32.
6. Loginov A. S., Reshetnyak V. I., Kaprelyants A. S. et al. The possibility of existence of Helicobacter pylori cells in dormant state in gastric mucosae. 11th World Congres of Gastroenterology Abstr Vienna, 1998; 471.
7. Gosciniak G., Kovacic D., Przondo-Mordarska A In vitro susceptibility of Helicobacter pylori strains to azithromycin. Proc 8th European Congr Clin Microbiol Infect Dis: Lausanne, 1997, abstr 945.
8. Bjorkholm B., Zhukhovitsky V., Lofinan C. et al. Helicobacter pylori entry into human gastric epithelial cells: A potential determinant of virulence, persistence, and treatment failures. Helicobacter 2000; 5: 3: 148-154.
9. Harrison J. D., Jones J. A., Morris D. L. Azithromicyn levels in plasma and gastric tissue, juice and mucus Eur J Clin Microbiol Infect Dis 1991; 10: 862-864.
10. Rigo R., Holmberg M., Engstrand L. Eradication of intracellular Helicobacter pylori in multidrug resistant monocytes using azithrimycin and lansoprazole. Gut 1996; 39: Suppl. 2: A10
11. Hulten K. , Cars O., Hjelm E., Engstrand L. In vitro activity of azithromycin against intracellular Helicobacter pylori J Antimicrob. Chemother. 1996; 37: 483-489.